Results 151 to 160 of about 23,850 (163)

Empagliflozin improves glycaemic and weight control as add-on therapy to pioglitazone or pioglitazone plus metformin in patients with type 2 diabetes: a 24-week, randomized, placebo-controlled trial

Diabetes, Obesity and Metabolism, 2014
Christopher S. Kovacs, H J Woerle, U C Broedl   +2 more
exaly  

Pioglitazone and bladder cancer risk: a systematic review and meta-analysis

Cancer Medicine, 2018
Shuangshuang Fu, Tiansheng Wang, Jiali Han   +2 more
exaly  

The effect of pioglitazone on weight, lipid profile and liver enzymes in type 2 diabetic patients

Therapeutic Advances in Endocrinology and Metabolism, 2015
Naser Aghamohammadzadeh, Elaheh Dalir Abdolahinia, Mitra Niafar   +2 more
exaly  

Pioglitazone for Secondary Stroke Prevention: A Systematic Review and Meta-Analysis

Stroke, 2017
Jeffrey L. Saver, Meng Lee, Bruce Ovbiagele   +2 more
exaly  

Interaction study of pioglitazone with albumin by fluorescence spectroscopy and molecular docking

Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2011
Bagher Larijani, Morteza Hosseini, Mohammad R. Ganjali   +2 more
exaly  

Pioglitazone: side effect and safety profile

Expert Opinion on Drug Safety, 2010
Sunder Mudaliar
exaly  

Increased risk of bladder cancer with pioglitazone therapy in patients with diabetes: A meta-analysis

Diabetes Research and Clinical Practice, 2012
Zhoujun Shen, Yingli Lu, Zhaowei Zhu
exaly  

PPARγ ligands, rosiglitazone and pioglitazone, inhibit bFGF- and VEGF-mediated angiogenesis

Angiogenesis, 2008
Ahmad Aljada, Shaker A Mousa
exaly  

Impact of pioglitazone on bone mineral density and bone marrow fat content

Osteoporosis International, 2017
Quan Yuan, B Adams-Huet
exaly  

Evidence for the Importance of Adiponectin in the Cardioprotective Effects of Pioglitazone

Hypertension, 2010
Xianwu Cheng, Kohzo Nagata, Toyoaki Murohara   +2 more
exaly